Augmentin Tablet 375mg, 625mg, 1g and Suspension (Co-amoxiclav)
GlaxoSmithKline Pakistan LimitedDRAP reg. 017297
We dispense this on prescription
We accept a prescription from any registered doctor in Pakistan.
Same day or next day in Karachi, Lahore, Islamabad, Rawalpindi for orders confirmed before 6pm. Tracked courier, 2 to 4 working days everywhere else. Delivery Rs 250 in Rawalpindi and Islamabad, Rs 300 everywhere else, cash on delivery. Delivery details
Prices in PKR, checked 28 October 2026.
What Augmentin is
Augmentin (co-amoxiclav: amoxicillin with clavulanic acid) is an antibiotic for short-term treatment of bacterial infections of the upper and lower respiratory tract, genito-urinary tract, skin and soft tissue, bones and joints, and teeth, according to GSK Pakistan’s prescribing information for Augmentin. We dispense it on prescription.
- Clavulanic acid protects the amoxicillin from enzymes some bacteria make to resist it: the UK product information for Augmentin 625mg says amoxicillin alone is broken down by those enzymes (beta-lactamases), and clavulanic acid inactivates some of them.
- Augmentin is registered with DRAP under a separate number for each form, made by GlaxoSmithKline Pakistan in Karachi, and listed on GSK Pakistan’s own product list.
- The UK patient leaflet for Augmentin says antibiotics have no effect against infections caused by viruses. GSK Pakistan’s prescribing information says Augmentin should be used in line with local antibiotic-prescribing guidelines.
- We found no Pakistani patient leaflet for Augmentin online; GSK Pakistan’s prescribing information for doctors is the Pakistani source on this page, with UK sources named where they are used. Dispensing it on prescription is our own policy.
- DRAP controls Augmentin’s prices: its price index sets Rs 301.78 for 6 tablets of 625 mg, effective 23 July 2026, and each of our prices is at or below DRAP’s figure for that pack.
The strengths, and how much of each ingredient
The number on the pack is the two ingredients added together, and the ratio between them is not the same in every strength.
| Form | Amoxicillin | Clavulanic acid | Ratio |
|---|---|---|---|
| Tablet 375 mg | Amoxicillin: 250 mg | Clavulanic acid: 125 mg | Ratio: 2:1 |
| Tablet 625 mg | Amoxicillin: 500 mg | Clavulanic acid: 125 mg | Ratio: 4:1 |
| Tablet 1 g (BD) | Amoxicillin: 875 mg | Clavulanic acid: 125 mg | Ratio: 7:1 |
| Suspension 156.25 mg/5 ml | Amoxicillin: 125 mg per 5 ml | Clavulanic acid: 31.25 mg per 5 ml | Ratio: 4:1 |
| DS suspension 312.5 mg/5 ml | Amoxicillin: 250 mg per 5 ml | Clavulanic acid: 62.5 mg per 5 ml | Ratio: 4:1 |
| BD suspension 457 mg/5 ml | Amoxicillin: 400 mg per 5 ml | Clavulanic acid: 57 mg per 5 ml | Ratio: 7:1 |
Because the ratios differ, one strength can’t simply be swapped for another by counting milligrams. Your doctor chooses the strength.
What is in each form, with DRAP registration
From the label claims in DRAP’s registry. Amoxicillin is present as amoxicillin trihydrate and clavulanic acid as potassium clavulanate.
| Form | Ingredients | Amount |
|---|---|---|
| Tablet 375 mg (DRAP reg. 006747) | Ingredients: Amoxicillin; clavulanic acid | Amount: 250 mg; 125 mg |
| Tablet 625 mg (DRAP reg. 017297) | Ingredients: Amoxicillin; clavulanic acid | Amount: 500 mg; 125 mg |
| Tablet 1 g BD (DRAP reg. 022244) | Ingredients: Amoxicillin; clavulanic acid | Amount: 875 mg; 125 mg |
| Suspension 156.25 mg/5 ml (DRAP reg. 009264) | Ingredients: Amoxicillin; clavulanic acid | Amount: 125 mg; 31.25 mg per 5 ml |
| DS suspension 312.5 mg/5 ml (DRAP reg. 018360D) | Ingredients: Amoxicillin; clavulanic acid | Amount: 250 mg; 62.5 mg per 5 ml |
| BD suspension 457 mg/5 ml (DRAP reg. 070662) | Ingredients: Amoxicillin; clavulanic acid | Amount: 400 mg; 57 mg per 5 ml |
DRAP’s price index prints the DS suspension’s number as 018360; in DRAP’s registry that number belongs to a different product, and the DS suspension’s record is 018360D.
GSK Pakistan’s prescribing information says the suspension contains aspartame, a source of phenylalanine, so it should be used with caution in people with phenylketonuria.
What it is used for
Bacterial infections only. Pakistan’s prescribing information lists them broadly; the UK label names specific infections.
| Source | Uses |
|---|---|
| Pakistan, GSK (Augmentin) | Short-term treatment of bacterial infections: upper and lower respiratory tract, genito-urinary tract, skin and soft tissue, bone and joint, and dental infections, and other infections such as intra-abdominal sepsis. |
| UK, Augmentin 625mg | Acute bacterial sinusitis; acute middle-ear infection (otitis media); flare-ups of chronic bronchitis; community-acquired pneumonia; cystitis; kidney infection (pyelonephritis); skin and soft tissue infections, in particular cellulitis, animal bites and severe dental abscess with spreading cellulitis; bone and joint infections, in particular osteomyelitis. |
How to take it
The dose depends on the infection, its severity, and the patient’s age, weight and kidney function, according to GSK Pakistan’s prescribing information for Augmentin, so the choice belongs to your prescriber. Take it as they direct.
- With food: the NHS says take it with a meal, which helps reduce side effects such as feeling or being sick. The UK label for the 457 mg suspension says to give it at the start of a meal, which also helps absorption.
- How long: the UK product information for Augmentin 625mg says treatment should not be extended beyond 14 days without review.
- Suspensions, once made up: the UK patient leaflet for Augmentin suspension says store it in a refrigerator, use it within 7 days, and shake the bottle well before each dose. Ask our pharmacist to make it up if you’re unsure how much water to add.
- Children: GSK Pakistan’s prescribing information says the 375 mg and 625 mg tablets are not recommended for children aged 12 or under; children’s doses depend on body weight.
Who should not take it, or should ask a doctor first
Pakistan’s and the UK’s wording of the allergy rule differ, so both are shown.
| Who | What the sources say |
|---|---|
| Allergy to antibiotics | Pakistan: must not be used with a history of hypersensitivity to beta-lactams, such as penicillins and cephalosporins. UK: must not be used with an allergy to any penicillin, or a history of a severe immediate allergic reaction, such as anaphylaxis, to another beta-lactam (a cephalosporin, carbapenem or monobactam). |
| Jaundice or liver problems with this medicine before | Pakistan and UK: must not be used. The UK label says liver problems may be severe, and may only appear weeks after treatment ends. |
| Glandular fever (infectious mononucleosis) | Pakistan and UK: should be avoided if glandular fever is suspected, because a measles-like rash has been linked with amoxicillin in this condition. |
| Liver or kidney disease | UK: use with caution where there is evidence of liver impairment; the dose depends on kidney function. |
Other medicines
Pakistan’s and the UK’s lists are not the same; each line names its source.
| Medicine | What the source says | Source |
|---|---|---|
| Warfarin, acenocoumarol | What the source says: Rare cases of a raised INR (slower blood clotting) have been reported; the doctor may need to check it. | Source: Pakistan; UK, 4.5 |
| Combined contraceptive pill | What the source says: Augmentin may affect the gut bacteria, lowering oestrogen reabsorption and reducing the pill’s effect. This is in Pakistan’s prescribing information; the UK label doesn’t list it. | Source: Pakistan |
| Methotrexate | What the source says: Penicillins may reduce its excretion and increase its toxicity. This is in the UK label; Pakistan’s prescribing information doesn’t list it. | Source: UK, 4.5 |
| Probenecid | What the source says: Use together is not recommended. | Source: Pakistan; UK, 4.5 |
| Allopurinol | What the source says: Can increase the likelihood of allergic skin reactions. | Source: Pakistan; UK, 4.4 |
| Mycophenolate mofetil | What the source says: Its active form’s level before each dose may fall by about half. | Source: Pakistan |
Pregnancy and breastfeeding
Ask your doctor before taking it if you are pregnant or breastfeeding.
| Who | What the sources say |
|---|---|
| Pregnancy | Pakistan: use should be avoided, especially in the first three months, unless the doctor considers it essential. UK: use should be avoided unless the doctor considers it essential, without singling out the first three months; it adds that one study linked it, when given to women whose waters broke early (preterm premature rupture of the membranes), with a higher risk of a serious bowel condition in newborns (necrotising enterocolitis). |
| Breastfeeding | Pakistan: may be given while breastfeeding. UK: only after the doctor has weighed the benefits and risks. NHS: you can usually take it while breastfeeding, but check with a pharmacist or doctor first. |
Side effects
Diarrhoea is the most common one, according to the UK product information for Augmentin 625mg.
| Source | Side effects |
|---|---|
| UK label (common) | Diarrhoea; thrush; feeling or being sick. |
| Serious (Pakistan and UK) | Severe allergic reactions, including severe skin reactions; inflammation of the large intestine with watery, sometimes bloody diarrhoea (antibiotic-associated colitis); hepatitis and jaundice. |
Driving: the NHS says co-amoxiclav will not usually affect driving, but if you feel dizzy, don’t drive, ride a bike or use machinery until it stops.
Checking your pack is genuine
DRAP has named two spurious batches of Augmentin 625mg tablets, 7F4W and YT9D, and says the YT9D sample contained no amoxicillin or clavulanic acid. If your pack’s batch number is either of these, do not take it.
- Check that the batch number on the carton matches the batch number on the strip inside, and that the pack is sealed.
- DRAP registers these products as Augmentin and, for the 1 g tablet and the 457 mg suspension, Augmentin BD. If a pack looks different from your last one, ask our pharmacist before taking it.
- If anything looks wrong, do not take it. Send us a photo of the carton and strip on WhatsApp, and report it to DRAP.
DRAP Rapid Alert No. I/S/10-26-43, 21 October 2026: Augmentin 625mg tablets, batch YT9D, purported to be made by GlaxoSmithKline Pakistan, declared spurious by the Drug Testing Laboratory Sindh, Karachi, because the sample did not contain amoxicillin or clavulanic acid. DRAP says the manufacturers disowned the samples.
DRAP Rapid Alert No. I/S/08-25-56, 20 August 2025: Augmentin 625mg tablets, batch 7F4W, purported to be made by GlaxoSmithKline Pakistan, declared spurious by the Drug Testing Laboratory, Multan.
We buy only from authorised distributors, and check the batch and expiry on every item before it is packed.
Information as of 28 October 2026. DRAP publishes new alerts on dra.gov.pk.
Returns and replacements
Medicines and supplements can’t be returned once they have left our pharmacy.
- Returned medicine can never go back into saleable stock. That is a safety rule, not a commercial one.
- If an item arrives damaged or wrong, tell us on WhatsApp within 24 hours and we replace it. That is us fixing our mistake, not a return.
- Anything that arrives expired or within a month of expiry we replace or refund, your choice, with no time limit.
Frequently asked questions
What is Augmentin 625 used for?
Augmentin is co-amoxiclav, an antibiotic. GSK Pakistan’s prescribing information lists bacterial infections of the respiratory tract, urinary tract, skin and soft tissues, bones and joints, and teeth. The UK patient leaflet says antibiotics have no effect against infections caused by viruses.
Can I take Augmentin if I am allergic to penicillin?
No. GSK Pakistan’s prescribing information says it must not be used by anyone with a history of allergy to beta-lactam antibiotics, such as penicillins and cephalosporins.
Should Augmentin be taken with food?
Yes. The NHS says take co-amoxiclav with a meal, which helps reduce side effects such as feeling or being sick.
Is Augmentin the same as Calamox?
Both contain the same two ingredients, amoxicillin and clavulanic acid (co-amoxiclav), according to DRAP’s registry and price index, which list Augmentin under GlaxoSmithKline Pakistan and Calamox under Bosch Pharmaceuticals. Take the brand and strength your doctor prescribes.
Do you need a prescription to buy Augmentin?
We dispense Augmentin on prescription. We found no Pakistani leaflet online that states its condition of sale, so this is our own policy; in the UK, the NHS says co-amoxiclav is only available with a prescription.
Related products
Novidat Tablets 250mg and 500mg (Ciprofloxacin)
Prescription required
500mg, 10 tablets
In stock
Rs 445
See Novidat
Flagyl Tablet 400mg and Suspension 200mg/5ml (Metronidazole)
We dispense this on prescription
Tablets 400mg, strip of 10
In stock
Rs 47.62
See Flagyl
Calamox Tablet 375mg, 625mg, 1g, Suspension and Drops (Co-amoxiclav)
Prescription required
Tablets 625mg, strip of 6
In stock
Rs 232.86
See Calamox
Questions about Augmentin Tablet 375mg, 625mg, 1g and Suspension (Co-amoxiclav)?
Send your question on WhatsApp and a pharmacist will come back to you.
Written by the ePharmacyy pharmacy team.
Last checked against the sources below on
DRAP registration
- Augmentin 625mg Tablet (017297), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Reviewed, “Not Verified”.
- Augmentin Tablets 375mg (006747), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Reviewed, “Not Verified”.
- Augmentin BD Tablet (022244), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Reviewed, “Not Verified”.
- Augmentin Suspension 156.25mg/5ml (009264), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Reviewed, “Not Verified”.
- Augmentin DS Suspension 312.5mg/5ml (018360D), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Approved / Finalized, “Not Verified”.
- Augmentin BD 457mg/5ml Suspension (070662), GlaxoSmithKline Pakistan Limited. DRAP’s registry shows: Reviewed, “Not Verified”.
DRAP publishes no definition of this verification flag, so we can’t tell you what it means. We searched DRAP’s website for “Augmentin”, “amoxicillin clavulanic” and “co-amoxiclav” on 28 October 2026 and found two alerts naming falsified Augmentin 625mg tablets, batches 7F4W and YT9D (below). When we tested it, the search did not find a word that appears only inside an alert’s attached PDF, so an alert that names a product only in its PDF may not show up. DRAP describes its registered products index as a provisional list that “cannot be used as a reference for any purpose”. Checked against the registry on .
Sources
- DRAP registered products: Augmentin Tablets 375mg, registration 006747
- DRAP registered products: Augmentin 625mg Tablet, registration 017297
- DRAP registered products: Augmentin BD Tablet, registration 022244
- DRAP registered products: Augmentin Suspension 156.25mg/5ml, registration 009264
- DRAP registered products: Augmentin DS Suspension 312.5mg/5ml, registration 018360D
- DRAP registered products: Augmentin BD 457mg/5ml Suspension, registration 070662
- DRAP notified price index: Augmentin and Calamox (effective 23 and 27 July 2026)
- DRAP registered products: Calamox Tablets 625mg, registration 021510
- GSK Pakistan: products A–Z
- GSK Pakistan: Augmentin oral, abbreviated prescribing information (GDS 23/IPI14, 15 August 2017)
- emc (UK): Augmentin 625mg tablets, summary of product characteristics (revised 24 February 2026)
- emc (UK): Augmentin 625mg tablets, patient information leaflet (revised September 2025)
- emc (UK): Augmentin 125/31 suspension, summary of product characteristics (revised 24 February 2026)
- emc (UK): Augmentin 125/31 suspension, patient information leaflet (revised September 2025)
- emc (UK): Augmentin-Duo 400/57 powder for oral suspension, summary of product characteristics (revised 8 October 2026)
- NHS: Co-amoxiclav
- DRAP Rapid Alert I/S/10-26-43: spurious Augmentin 625mg tablet and others (21 October 2026)
- DRAP Rapid Alert I/S/08-25-56: falsified and spurious drug products (20 August 2025)